(Q39258427)

English

Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

type 2 diabetes

0 references

author name string

M Ben Hadj Mohamed

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

N Mtiraoui

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

I Ezzidi

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M Chaieb

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

T Mahjoub

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

W Y Almawi

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

937-943

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Type-2 diabetes: a cocktail of genetic discovery.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The Pro12Ala polymorphism of PPARγ2 gene and susceptibility to type 2 diabetes mellitus in a Polish population

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in young schoolchildren

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Free fatty acids, insulin resistance, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor γ Associated With Carotid Atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FBF03349241

21 January 2018

Genetics of type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18250615

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03349241

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

release_bequzzcwkrcgthslkn4s7wsjba

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39258427&oldid=2202729990"